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Abstract
The concept of allostery in which macromolecules switch between two different conforma-
tions is a central theme in biological processes ranging from gene regulation to cell signaling
to enzymology. Allosteric enzymes pervade metabolic processes, yet a simple and unified
treatment of the effects of allostery in enzymes has been lacking. In this work, we take the
first step towards this goal by modeling allosteric enzymes and their interaction with two key
molecular players - allosteric regulators and competitive inhibitors. We then apply this model
to characterize existing data on enzyme activity, comment on how enzyme parameters (such as
substrate binding affinity) can be experimentally tuned, and make novel predictions on how to
control phenomena such as substrate inhibition.
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1 Introduction
All but the simplest of cellular reactions are catalyzed by enzymes, macromolecules that can in-
crease the rates of reactions by many orders of magnitude. In some cases, such as phosphoryl
transfer reactions, rate enhancements can be as large as 1020-fold or more.1 A deeper understand-
ing of how enzymes work can provide insights into biological phenomena as diverse as metabolic
regulation or the treatment of disease.2–4 The basic principles of enzyme mechanics were first
proposed by Michaelis and Menten5 and later extended by others.6–8 While the earliest models
considered enzymes as single-state catalysts, experiments soon revealed that some enzymes ex-
hibit richer dynamics.9,10 The concept of allosteric enzymes was introduced by Monod-Wyman-
Changeux (MWC) and independently by Pardee and Gerhart,7,11–13 providing a much broader
framework for explaining the full diversity of enzyme behavior. Since then, the MWC concept
in which macromolecules are thought of as having both an inactive and active state has spread
into many fields, proving to be a powerful conceptual tool capable of explaining many biological
phenomena.14–16
Enzymology is a well studied field, and much has been learned both theoretically and ex-
perimentally about how enzymes operate.17–20 With the vast number of distinct molecular play-
ers involved in enzymatic reactions (for example: mixed, competitive, uncompetitive, and non-
competitive inhibitors as well as cofactors, allosteric effectors, and substrate molecules), it is not
surprising that new discoveries continue to emerge about the subtleties of enzyme action.9,21,22 In
this paper, we use the MWC model to form a unifying framework capable of describing the broad
array of behaviors available to allosteric enzymes.
Statistical mechanics is a field of physics that describes the collective behavior of large numbers
of molecules. Historically developed to understand the motion of gases, statistical physics has now
seen applications in many areas of biology and has provided unexpected connections between dis-
tinct problems such as how transcription factors are induced by signals from the environment, the
function of the molecular machinery responsible for detecting small gradients in chemoattractants,
the gating properties of ligand-gated ion channels, and even the accessibility of genomic DNA in
eukaryotes which is packed into nucleosomes.23–29 One of us (RP) owes his introduction to the
many beautiful uses of statistical mechanics in biology to Bill Gelbart to whom this special issue
is dedicated. During his inspiring career, Gelbart has been a passionate and creative developer of
insights into a wide number of problems using the tools of statistical mechanics and we hope that
our examples on the statistical mechanics of allosteric enzymes will please him.
The remainder of the paper is organized as follows. In section 2.1, we show how the theoretical
treatment of the traditional Michaelis-Menten enzyme, an inherently non-equilibrium system, can
be stated in a language remarkably similar to equilibrium statistical mechanics. This sets the stage
for the remainder of the paper by introducing key notation and the states and weights formalism
that serves as the basis for analyzing more sophisticated molecular scenarios. In section 2.2, we
discuss how the states and weights formalism can be used to work out the rates for the simplest
MWC enzyme, an allosteric enzyme with a single substrate binding site. This is followed by a
discussion of how allosteric enzymes are modified by the binding of ligands, first an allosteric
regulator in section 2.3 and then a competitive inhibitor in section 2.4. We next generalize to
the much richer case of enzymes with multiple substrate binding sites in section 2.5. Lastly, we
discuss how to combine the individual building blocks of allostery, allosteric effectors, competitive
inhibitors, and multiple binding sites to analyze general enzymes in section 2.6. Having built up
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this framework, we then apply our model to understand observed enzyme behavior. In section 3.1,
we show how disparate enzyme activity curves can be unified within our model and collapsed
onto a single curve. We close by examining the exotic phenomenon of substrate inhibition in
section 3.2 and show how the allosteric nature of some enzymes may be the key to understanding
and controlling this phenomenon.
2 Models
2.1 Michaelis-Menten Enzyme
We begin by briefly introducing the textbook Michaelis-Menten treatment of enzymes.18 This will
serve both to introduce basic notation and to explain the states and weights methodology which we
will use throughout the paper.
Many enzyme-catalyzed biochemical reactions are characterized by Michaelis-Menten kinet-
ics. Such enzymes comprise a simple but important class where we can study the relationship be-
tween the traditional chemical kinetics based on reaction rates with a physical view dictated by sta-
tistical mechanics. According to the Michaelis-Menten model, enzymes are single-state catalysts
that bind a substrate and promote its conversion into a product. Although this scheme precludes
allosteric interactions, a significant fraction of non-regulatory enzymes (e.g. triosephosphate iso-
merase, bisphosphoglycerate mutase, adenylate cyclase) are well described by Michaelis-Menten
kinetics.18
The key player in this reaction framework is a monomeric enzyme E which binds a substrate
S at the substrate binding site (also called the active site or catalytic site), forming an enzyme-
substrate complex ES. The enzyme then converts the substrate into product P which is subse-
quently removed from the system and cannot return to its original state as substrate. In terms of
concentrations, this reaction can be written as
[E ]+[S ] [ES ]konkoff
kcat [E ]+[P ] (1)
where the rate of product formation equals
d[P]
dt
= [ES]kcat . (2)
Briggs and Haldane assumed a time scale separation where the substrate and product concen-
trations ([S] and [P]) slowly change over time while the free and bound enzyme states ([E] and
[ES]) changed much more rapidly.6 This allows us to approximate this system over short time
scales by assuming that the slow components (in this case [S]) remain constant and can therefore
be absorbed into the kon rate,30
[E ] [ES ].kon[S ]koff + kcat (3)
Assuming that the system (3) reaches steady-state (over the short time scale of this approximation)
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quickly enough that the substrate concentration does not appreciably diminish, this implies
[E][S]kon = [ES]
(
ko f f + kcat
)
, (4)
which we can rewrite as
[ES]
[E]
=
[S]kon
ko f f + kcat
≡ [S]
KM
(5)
where KM =
ko f f+kcat
kon
is called the Michaelis constant. KM incorporates the binding and unbinding
of ligand as well as the conversion of substrate into product; in the limit kcat = 0, KM reduces
to the familiar dissociation constant KD =
ko f f
kon
. Using Eq (5) and the fact that the total enzyme
concentration is conserved, [E]+ [ES] = [Etot ], we can solve for [E] and [ES] separately as
[E] = [Etot ]
1
1+ [S]KM
≡ [Etot ]pE (6)
[ES] = [Etot ]
[S]
KM
1+ [S]KM
≡ [Etot ]pES, (7)
where pE =
[E]
[Etot ]
and pES =
[ES]
[Etot ]
are the probabilities of finding an enzyme in the unbound and
bound form, respectively. Substituting the concentration of bound enzymes [ES] from Eq (7) into
the rate of product formation Eq (2),
d[P]
dt
= kcat [Etot ]
[S]
KM
1+ [S]KM
. (8)
Figure 1 shows the probability of free and bound enzyme as well as the rate of product formation.
The two parameters kcat and [Etot ] scale
d[P]
dt vertically (if kcat is increased by a factor of 10, the
y-axis values in Figure 1B will be multiplied by that same factor of 10), while KM effectively
rescales the substrate concentration [S]. Increasing KM by a factor of 10 implies that 10 times as
much substrate is needed to obtain the same rate of product formation; on the semi-log plots in
Figure 1 this corresponds to shifting all curves to the right by one power of 10.
We can visualize the microscopic states of the enzyme using a modified states and weights
diagram shown in Figure 2.31 The weight of each enzyme state is proportional to the probability of
its corresponding state (wE ∝ pE , wES ∝ pES) - the constant of proportionality is arbitrary but must
be the same for all weights. For example, from Eqs (6) and (7) we can multiply the probability that
the enzyme will be unbound (pE) or bound to substrate (pES) by 1+
[S]
KM
which yields the weights
wE = 1 (9)
wES =
[S]
KM
. (10)
Given the weights of an enzyme state, we can proceed in the reverse direction and obtain the
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Figure 1: Dynamics of the Michaelis-Menten enzyme. (A) Probabilities of the free enzyme pE and bound
enzyme pES states as a function of substrate concentration. As the amount of substrate [S] increases, more
enzyme is found in the bound state rather than the free state. (B) The rate of product formation for a non-
allosteric enzyme. The rate of product formation has the same functional form as the probability pES of the
enzyme-substrate complex, as illustrated by Eqs (2) and (7).
0
kcat
[S ]
KM
STATE RATEWEIGHT
1
Figure 2: States and weights for the Michaelis-Menten enzyme. Each enzyme conformation is shown
together with its weight and its catalytic rate. The probability of finding an enzyme (green) in either the free
or bound state equals the weight of that state divided by the sum of all weights (1+ [S]KM ) where [S] is the
concentration of substrate (dark red) and KM =
ko f f+kcat
kon
is the Michaelis constant. At [S] = KM, half of the
enzyme population exists in the free form and half exists in the bound form. For [S] > KM, more than half
of all enzymes will be bound to substrate.
probability for each enzyme state using
pE =
wE
Ztot
=
1
1+ [S]KM
(11)
pES =
wES
Ztot
=
[S]
KM
1+ [S]KM
(12)
where
Ztot = wE +wES (13)
is the sum of all weights. Dividing by Ztot ensures the total probability of all enzyme states equals
unity, pE + pES = 1. The rate of product formation Eq (8) is given by the product of the enzyme
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concentration [Etot ] times the average catalytic rate over all states, weighed by each state’s (nor-
malized) weights. In the following sections, we will find this trick of writing states and weights
very useful for modeling other molecular players.
The weights in Figure 2 allow us to easily understand Figure 1A: when [S] < KM, wE > wES
so that an enzyme is more likely to be in the substrate-free state; when [S] > KM, wE < wES
and an enzyme is more likely to be found as an enzyme-substrate complex. Increasing KM shifts
the tipping point of how much substrate is needed before the bound ES enzyme state begins to
dominate over the free E state.
It should be noted that the formal notion of states and weights employed in physics applies only
to equilibrium systems. For example, a ligand binding to a receptor in equilibrium will yield states
and weights similar to Figure 2 but with the Michaelis constant KM replaced by the dissociation
constant KD.32 Yet the ligand-receptor states and weights can also be derived from the Boltzmann
distribution (where the weight of any state j with energy E j is proportional to e−βE j) while the
enzyme states and weights cannot be derived from the Boltzmann distribution (because the enzyme
system is not in equilibrium). Instead, the non-equilibrium kinetics of the system are described by
the modified states and weights in Figure 2, where the KD for substrate must be replaced with
KM. These modified states and weights serve as a mathematical trick that compactly and correctly
represents the behavior of the enzyme, enabling us to apply the well established tools and intuition
of equilibrium statistical mechanics when analyzing the inherently non-equilibrium problem of
enzyme kinetics. In the next several sections, we will show how to generalize this method of
states and weights to MWC enzymes with competitive inhibitors, allosteric regulators, and multiple
substrate binding sites.
2.2 MWC Enzyme
Many enzymes are not static entities, but dynamic macromolecules that constantly fluctuate be-
tween different conformational states. This notion was initially conceived by Monod-Wyman-
Changeux (MWC) to characterize complex multi-subunit proteins such as hemoglobin and as-
partate transcarbamoylase (ATCase).7,11,12 The authors suggested that the ATC enzyme exists in
two supramolecular states: a relaxed “R” state, which has high-affinity for substrate and a tight
“T” state, which has low-affinity for substrate. Although in the case of ATCase, the transition
between the T and R states is induced by an external ligand, recent experimental advances have
shown that many proteins intrinsically fluctuate between these different states even in the absence
of ligand.33–35 These observations imply that the MWC model can be applied to a wide range of
enzymes beyond those with multi-subunit complexes.
We will designate an enzyme with two possible states (an Active state EA and an Inactive state
EI) as an MWC enzyme. The kinetics of a general MWC enzyme are given by
[EA]+[S ] [EAS ]
konA
koffA
[EI ]+[S ] [EIS ]
koffI
ktransA ktransI
konI
ktransAS ktransIS
kcatA
kcatI
[EA]+[P ]
[EI ]+[P ],
(14)
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which relates the active and inactive enzyme concentrations ([EA], [EI]) to the active and inactive
enzyme-substrate complexes ([EAS], [EIS]). In this two-state MWC model, similar to that explored
by Howlett et al.,36 the rate of product formation is given by
d[P]
dt
= kAcat [EAS]+ k
I
cat [EIS]. (15)
The active state will have a faster catalytic rate (often much faster) than the inactive state, kAcat >
kIcat .
As in the case of a Michaelis-Menten enzyme, we will assume that all four forms of the enzyme
(EA, EI , EAS, and EIS) quickly reach steady state on time scales so short that the substrate concen-
tration [S] remains nearly constant. Therefore, we can incorporate the slowly-changing quantities
[S] and [P] into the rates, a step dubbed the quasi-steady-state approximation.30 This allows us to
rewrite the scheme (14) in the following form,
[EA] [EAS ]
kon[S ]A
[EI ] [EIS ].
ktransA ktransI
kon[S ]I
ktransAS ktransIS
koff   +kcatA A
koff   +kcatI I
(16)
Assuming the quasi-steady-state approximation holds, the four enzyme states will rapidly attain
steady-state values
d[EAS]
dt
=
d[EA]
dt
=
d[EIS]
dt
=
d[EI]
dt
= 0. (17)
In addition, a separate constraint on the system that is necessary and sufficient to apply the method
of states and weights is given by the cycle condition: the product of rates going clockwise around
any cycle must equal the product of rates going counterclockwise.30 It should be noted that to
violate the cycle condition, a system must continuously pay energy since at least one step in any
cycle must be energetically unfavorable. We shall proceed with the assumption that there are no
such cycles in our system. For the MWC enzyme (16), this implies(
kAon[S]
)
kAStrans
(
kIo f f + k
I
cat
)
kItrans =
(
kAo f f + k
A
cat
)
kAtrans
(
kIon[S]
)
kIStrans (18)
or equivalently
kAon[S]
kAo f f + k
A
cat︸ ︷︷ ︸
[EAS]
[EA]
kItrans
kAtrans︸ ︷︷ ︸
[EA]
[EI ]
=
kIon[S]
kIo f f + k
I
cat︸ ︷︷ ︸
[EIS]
[EI ]
kIStrans
kAStrans︸ ︷︷ ︸
[EAS]
[EIS]
. (19)
The validity of both the quasi-steady-state approximation (17) and the cycle condition (19)
will be analyzed in Appendix A. Assuming both statements hold, we can invoke detailed balance
- the ratio of concentrations between two enzyme states equals the inverse of the ratio of rates
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Figure 3: States and weights for an MWC enzyme. The energies εA and εI provide the free energy scale
for the substrate-free conformations, dictating their relative probabilities. Decreasing the energy εA of the
active state would increase the probability of all the active enzyme conformations relative to the inactive
conformations. KAM denotes the substrate concentration at which half of the active enzymes are bound and
half the active enzymes are unbound, as indicated by the crossing of the (pEA , blue) and (pEAS, gold) curves
at [S] = KAM in Figure 4. K
I
M serves an analogous role for the inactive states.
connecting these two states. For example, between the active states [EAS] and [EA] in (16),
[EAS]
[EA]
=
kAon[S]
kAo f f + k
A
cat
≡ [S]
KAM
(20)
where we have defined the Michaelis constant for the active state, KAM. Similarly, we can write the
equation for detailed balance between the inactive states [EIS] and [EI] as
[EIS]
[EI]
=
kIon[S]
kIo f f + k
I
cat
≡ [S]
KIM
. (21)
An enzyme may have a different affinity for substrate or a different catalytic rate in the active and
inactive forms. Typical measured values of KM fall into the range 10−7−10−1 M.37 Whether KAM
or KIM is larger depends on the specific enzyme.
As a final link between the language of chemical rates and physical energies, we can recast
detailed balance between [EA] and [EI] as
[EA]
[EI]
=
kItrans
kAtrans
≡ e−β (εA−εI), (22)
where εA and εI are the free energies of the enzyme in the active and inactive state, respectively,
and β = 1kBT where kB is Boltzmann’s constant and T is the temperature of the system. Whether
the active state energy is greater than or less than the inactive state energy depends on the enzyme.
For example, εI < εA in ATCase whereas the opposite holds true, εA < εI , in chemoreceptors.9,32
Using Eqs (20)-(22), we can recast the cycle condition (19) (as shown in the under-braces) into
a simple relationship between the steady-state enzyme concentrations. Additionally, we can use
these equations to define the weights of each enzyme state in Figure 3. Following section 2.1, the
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probability of each state equals its weight divided by the sum of all weights,
pEA = e
−βεA 1
Ztot
(23)
pEAS = e
−βεA
[S]
KAM
Ztot
(24)
pEI = e
−βεI 1
Ztot
(25)
pEIS = e
−βεI
[S]
KIM
Ztot
, (26)
where
Ztot = e−βεA
(
1+
[S]
KAM
)
+ e−βεI
(
1+
[S]
KIM
)
. (27)
Note that multiplying all of the weights by a constant c will also multiply Ztot by c, so that the
probability of any state will remain unchanged. That is why in Figure 2 we could neglect the e−βε
factor that was implicitly present in each weight.
The total amount of enzyme is conserved among the four enzyme states, [Etot ] = [EA]+[EAS]+
[EI]+ [EIS]. Using this fact together with Eqs (20)-(22) enables us to solve for the concentrations
of both types of bound enzymes, namely,
[EAS] = [Etot ]
e−βεA [S]
KAM
e−βεA
(
1+ [S]
KAM
)
+ e−βεI
(
1+ [S]KIM
) = [Etot ]pEAS (28)
[EIS] = [Etot ]
e−βεI [S]KIM
e−βεA
(
1+ [S]
KAM
)
+ e−βεI
(
1+ [S]KIM
) = [Etot ]pEIS. (29)
Substituting these relations into (15) yields the rate of product formation,
d[P]
dt
= [Etot ]
kAcate
−βεA [S]
KAM
+ kIcate
−βεI [S]
KIM
e−βεA
(
1+ [S]
KAM
)
+ e−βεI
(
1+ [S]KIM
) . (30)
The probabilities (23)-(26) of the different states and the rate of product formation (30) are shown
in Figure 4. Although we use the same parameters from Figure 1 for the active state, the pEA and
pEAS curves in Figure 4A look markedly different from the pE and pES Michaelis-Menten curves
in Figure 1A. This indicates that the activity of an MWC enzyme does not equal the activity of two
independent Michaelis-Menten enzymes, one with the MWC enzyme’s active state parameters
and the other with the MWC enzyme’s inactive state parameters. The interplay of the active and
inactive states makes an MWC enzyme inherently more complex than a Michaelis-Menten enzyme.
When [S] = 0 the enzyme only exists in the unbound states EA and EI whose relative probabil-
ities are given by
pEA
pEI
= e−β (εA−εI). When [S]→ ∞, the enzyme spends all of its time in the bound
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states EAS and EIS which have relative probabilities
pEAS
pEIS
= e−β (εA−εI)K
I
M
KAM
. The curves for the active
states (for free enzyme pEA and bound enzyme pEAS) intersect at [S] = K
A
M while the curves of the
two inactive states intersect at [S] = KIM. For the particular parameters shown, even though the un-
bound inactive state (green) dominates at low substrate concentrations, the active state (gold) has
the largest statistical weights as the concentration of substrate increases. Thus, adding substrate
causes the enzyme to increasingly favor the active state.
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Figure 4: Quantitative description of an MWC enzyme. (A) Probabilities of each enzyme state. While
the active state has the same catalytic rate kAcat and Michaelis constant K
A
M as the Michaelis-Menten enzyme in
Figure 1A, the inactive state significantly alters the forms of pEA and pEAS. The dashed vertical lines indicate
where the substrate concentration equals KAM and K
I
M, respectively. (B) The rate of product formation,
d[P]
dt .
Assuming k
A
cat
kIcat
 1, d[P]dt (blue curve in (B)) is dominated by the active enzyme-substrate complex, pEAS (gold
curve in (A)). Parameters were chosen to reflect “typical” enzyme kinetics values: k
A
cat
kIcat
= 102, K
A
M
KIM
= 10−1,
and e−β (εA−εI) = e−1.38 Substrate concentrations are shown normalized relative to the active state parameter
[S]
KAM
, although the inactive state parameter [S]KIM
could also have been used.
Using this framework, we can compute properties of the enzyme kinetics curve shown in Fig-
ure 4(B). One important property is the dynamic range of an enzyme, the difference between the
maximum and minimum rate of product formation. In the absence of substrate ([S]→ 0) and a
saturating concentration of substrate ([S]→ ∞), the rate of product formation Eq (30) becomes
lim
[S]→0
d[P]
dt
= 0 (31)
lim
[S]→∞
d[P]
dt
= [Etot ]
kAcat
e−βεA
KAM
+ kIcat
e−βεI
KIM
e−βεA
KAM
+ e
−βεI
KIM
. (32)
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From these two expressions, we can write the dynamic range as
dynamic range =
(
lim
[S]→∞
d[P]
dt
)
−
(
lim
[S]→0
d[P]
dt
)
= [Etot ]kAcat
1− 1− k
I
cat
kAcat
1+ e−β (εA−εI)K
I
M
KAM
 (33)
where every term in the fraction has been written as a ratio of the active and inactive state pa-
rameters. We find that the dynamic range increases as k
I
cat
kAcat
, e−β (εA−εI), and K
I
M
KAM
increase (assuming
kAcat > k
I
cat).
Another important property is the concentration of substrate at which the rate of product for-
mation lies halfway between its minimum and maximum value, which we will denote as [S50]. It
is straightforward to show that the definition
lim
[S]→[S50]
d[P]
dt
=
1
2
(
lim
[S]→∞
d[P]
dt
+ lim
[S]→0
d[P]
dt
)
(34)
is satisfied when
[S50] = KAM
e−β (εA−εI)+1
e−β (εA−εI)+ K
A
M
KIM
. (35)
With increasing e−β (εA−εI), the value of [S50] increases if KAM > KIM and decreases otherwise. [S50]
always decreases as K
A
M
KIM
increases. Lastly, we note that in the limit of a Michaelis-Menten enzyme,
εI → ∞, we recoup the familiar results
dynamic range = [Etot ]kAcat (εI → ∞) (36)
[S50] = KAM (εI → ∞). (37)
2.3 Allosteric Regulator
The catalytic activity of many enzymes is controlled by molecules that bind to regulatory sites
which are often different from the active sites themselves. As a result of ligand-induced con-
formational changes, these molecules alter the substrate binding site which modifies the rate of
product formation, d[P]dt . Allosterically controlled enzymes represent important regulatory nodes in
metabolic pathways and are often responsible for keeping cells in homeostasis. Some well-studied
examples of allosteric control include glycogen phosphorylase, phosphofructokinase, glutamine
synthetase, and aspartate transcarbamoylase (ATCase). In many cases the data from these systems
are characterized phenomenologically using Hill functions, but the Hill coefficients thus obtained
can be difficult to interpret.39 In addition, Hill coefficients do not provide much information about
the organization or regulation of an enzyme, nor do they reflect the relative probabilities of the
possible enzyme conformations, although recent results have begun to address these issues.40 In
this section, we add one more layer of complexity to our statistical mechanics framework by intro-
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ducing an allosteric regulator.
kcat
A
kcat
A
e-βεA
[S ]
KM
e-βεA A
0
[R ]
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[S ]
KM
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A kcat
I
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I
0
0
e-βεI
[S ]
KM
e-βεI I
[R ]
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e-βεI I
[S ]
KM
e-βεI I
[R ]
RD
I
STATE RATEWEIGHT STATE RATEWEIGHT
ACTIVE
STATES
INACTIVE
STATES
Figure 5: States and weights for an MWC enzyme with an allosteric regulator. The allosteric regulator
(purple) does not directly interact with the substrate (dark red) but instead introduces a factor [R]RD into the
weights where RD is a dissociation constant. Note that the regulator can only associate to and dissociate
from the enzyme, whereas substrate can be turned into product as shown by the Michaelis constant KM.
An allosteric activator binds more tightly to the active state enzyme, RAD < R
I
D, which leads to an increased
rate of product formation because the active state catalyzes substrate at a faster rate than the inactive state,
kAcat > k
I
cat . An allosteric inhibitor would satisfy R
A
D > R
I
D.
Consider an MWC enzyme with one site for an allosteric regulator R and a different site for a
substrate molecule S that will be converted into product. We can define the effects of the allosteric
regulator directly through the states and weights. As shown in Figure 5, the regulator R contributes
a factor [R]
RAD
when it binds to an active state and a factor [R]RID
when it binds to an inactive state where
RAD and R
I
D are the dissociation constants between the regulator and the active and inactive states
of the enzyme, respectively. Unlike the Michaelis constants KAM and K
I
M for the substrate, the
dissociation constants RAD and R
I
D enter the states and weights because the regulator can only bind
and unbind to the enzyme (and cannot be transformed into product). In other words, if we were to
draw a rates diagram for this enzyme system, detailed balance between the two states where the
regulator is bound and unbound would yield a dissociation constant ( ko f fkon ) rather than a Michaelis
constant ( ko f f+kcatkon ).
Using the states and weights in Figure 5, we can compute the probability of each enzyme state.
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For example, the probabilities of the four states that form product are given by
pEAS = e
−βεA
[S]
KAM
Ztot
(38)
pEASR = e
−βεA
[S]
KAM
[R]
RAD
Ztot
(39)
pEIS = e
−βεI
[S]
KIM
Ztot
(40)
pEISR = e
−βεI
[S]
KIM
[R]
RID
Ztot
(41)
where
Ztot = e−βεA
(
1+
[S]
KAM
)(
1+
[R]
RAD
)
+ e−βεI
(
1+
[S]
KIM
)(
1+
[R]
RID
)
(42)
is the sum of all weights in Figure 5. An allosteric activator has a smaller dissociation constant
RAD <R
I
D for binding to the active state enzyme, so that for larger [R] the probability that the enzyme
will be in the active state increases. Because the active state catalyzes substrate at a faster rate than
the inactive state, kAcat > k
I
cat , adding an activator increases the rate of product formation
d[P]
dt . An
allosteric inhibitor has the flipped relation RAD > R
I
D and hence causes the opposite effects.
Proceeding analogously to section 2.2, the total enzyme concentration [Etot ] is a conserved
quantity which equals the sum of all enzyme states ([EA], [EAS], [EAR], [EASR], and their inactive
state counterparts). Using the probabilities in Eqs (38)-(41), we can write these concentrations as
[EAS] = [Etot ]pEAS, [EASR] = [Etot ]pEASR, ... so that the rate of product formation is given by
d[P]
dt
= kAcat ([EAS]+ [EASR])+ k
I
cat ([EIS]+ [EISR])
= [Etot ]
kAcate
−βεA [S]
KAM
(
1+ [R]
RAD
)
+ kIcate
−βεI [S]
KIM
(
1+ [R]RID
)
e−βεA
(
1+ [S]
KAM
)(
1+ [R]
RAD
)
+ e−βεI
(
1+ [S]KIM
)(
1+ [R]RID
) . (43)
The rate of product formation (43) for different [R] values is shown in Figure 6. It is important
to realize that by choosing the weights in Figure 5, we have selected a particular model for the
allosteric regulator, namely one in which the regulator binds equally well to an enzyme with or
without substrate. There are many other possible models. For example, we could add an inter-
action energy between an allosteric regulator and a bound substrate. However, the simple model
in Figure 5 already possesses the important feature that adding more allosteric activator yields a
larger rate of product formation d[P]dt , as shown in Figure 6.
An allosteric regulator effectively tunes the energies of the active and inactive states. To better
understand this, consider the probability of an active state enzyme-substrate complex (with or
13
[R]/R
D
A =102[R]/R
D
A =101[R]/R
D
A =100  [R]/R
D
A =10-1
10-2 10-1 100 101 1020.0
0.2
0.4
0.6
0.8
1.0
[S]K
M
A
ⅆ[P]/ⅆ
t
k catA [E
to
t]-1
Increasing[R]/R
D
A
Figure 6: Effects of an allosteric regulator R on the rate of product formation d[P]dt . The regulator’s
greater affinity for the active enzyme state increases the fraction of the active conformations and hence d[P]dt .
Parameters used were R
A
D
RID
= 10−2 and the parameters from Figure 4.
without a bound regulator). Adding Eqs (38) and (39),
pEAS+ pEASR =
e−βεA [S]
KAM
(
1+ [R]
RAD
)
e−βεA
(
1+ [S]
KAM
)(
1+ [R]
RAD
)
+ e−βεI
(
1+ [S]KIM
)(
1+ [R]RID
)
≡
e−β ε˜A [S]
KAM
e−β ε˜A
(
1+ [S]
KAM
)
+ e−β ε˜I
(
1+ [S]KIM
) (44)
where
ε˜A = εA− 1β log
(
1+
[R]
RAD
)
(45)
ε˜I = εI− 1β log
(
1+
[R]
RID
)
. (46)
We now compare the total probability that an active state enzyme will be bound to substrate in
the presence of an allosteric regulator (Eq (44)) to this probability in the absence of an allosteric
regulator (Eq (24)). These two equations show that an MWC enzyme in the presence of regulator
concentration [R] is equivalent to an MWC enzyme with no regulator provided that we use the
new energies ε˜A and ε˜I for the active and inactive states. An analogous statement holds for all the
conformations of the enzyme, so that the effects of a regulator can be completely absorbed into
the energies of the active and inactive states! In other words, adding an allosteric regulator allows
us to tune the parameters εA and εI of an allosteric enzyme, and thus change its rate of product
formation, in a quantifiable manner. This simple result emerges from our assumptions that the
allosteric regulator and substrate bind independently to the enzyme and that the allosteric regulator
does not effect the rate of product formation.
One application of this result is that we can easily compute the dynamic range of an enzyme
as well as the concentration of substrate for half-maximal rate of product formation discussed in
section 2.2. Both of these quantities follow from the analogous expressions for an MWC enzyme
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(Eqs (33) and (35)) using the effective energies ε˜A and ε˜I , resulting in a dynamic range of the form
dynamic range = [Etot ]kAcat
1− 1− k
I
cat
kAcat
1+ e−β (εA−εI) 1+[R]/R
A
D
1+[R]/RID
KIM
KAM
 (47)
and an [S50] value of
[S50] = KAM
e−β (εA−εI) 1+[R]/R
A
D
1+[R]/RID
+1
e−β (εA−εI) 1+[R]/R
A
D
1+[R]/RID
+
KAM
KIM
. (48)
As expected, the dynamic range of an enzyme increases with regulator concentration [R] for an
allosteric activator (RAD < R
I
D). Adding more activator will shift [S50] to the left if K
A
M < K
I
M (as
shown in Figure 6) or to the right if KAM > K
I
M. The opposite effects hold for an allosteric inhibitor
(RID < R
A
D).
2.4 Competitive Inhibitor
Another level of control found in many enzymes is inhibition. A competitive inhibitor C binds
to the same active site as substrate S, yet unlike the substrate, the competitive inhibitor cannot be
turned into product by the enzyme. An enzyme with a single active site can either exist in the
unbound state E, as an enzyme-substrate complex ES, or as an enzyme-competitor complex EC.
As more inhibitor is added to the system, it crowds out the substrate from the enzyme’s active site
which decreases product formation. Many cancer drugs (e.g. lapatinib, sorafenib, erlotinib) are
competitive inhibitors for kinases involved in signaling pathways.41
e-βεA 0 0e-βεI
kcat
A[S ]
KM
e-βεA A kcat
I[S ]
KM
e-βεI I
0 0[C ]
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e-βεA A
[C ]
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e-βεI I
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Figure 7: States and weights for an MWC enzyme with a competitive inhibitor. While the substrate
S (dark red) can be transformed into product, the inhibitor C (light blue) can occupy the substrate binding
site but cannot be catalyzed. As seen with the allosteric regulator in section 2.3, the competitive inhibitor
contributes a factor [C]CD to the statistical weight of a state where CD is the inhibitor’s dissociation constant.
Starting from our model of an MWC enzyme in Figure 3, we can introduce a competitive
inhibitor by drawing two new states (an enzyme-competitor complex in the active and inactive
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forms) as shown in Figure 7. Only the enzyme-substrate complex in the active (EAS) and inactive
(EIS) states form product. The probabilities of each of these states is given by Eqs (24) and (26)
but using the new partition function (which includes the competitive inhibitor states),
Ztot = e−βεA
(
1+
[S]
KAM
+
[C]
CAD
)
+ e−βεI
(
1+
[S]
KIM
+
[C]
CID
)
. (49)
Repeating the same analysis from section 2.2, we write the concentrations of bound enzymes as
[EAS] = [Etot ]pEAS and [EIS] = [Etot ]pEIS, where [Etot ] is the total concentration of enzymes in
the system and pEA,IS is the weight of the bound (in)active state enzyme divided by the partition
function, Eq (49). Thus the rate of product formation equals
d[P]
dt
= kAcat [EAS]+ k
I
cat [EIS]
= [Etot ]
kAcate
−βεA [S]
KAM
+ kIcate
−βεI [S]
KIM
e−βεA
(
1+ [S]
KAM
+ [C]
CAD
)
+ e−βεI
(
1+ [S]KIM
+ [C]CID
) . (50)
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Figure 8: Effects of a competitive inhibitorC on the rate of product formation d[P]dt . When [C].CAD,CID,
the inhibitor cannot out-compete the substrate at high substrate concentrations while the free form of enzyme
dominates at low substrate concentrations. Therefore increasing [C] up to values of ≈ CAD or CID has little
effect on d[P]dt . Once [C] &CAD,CID, the inhibitor can out-compete substrate at large concentrations, pushing
the region where the enzyme-substrate complex dominates further to the right. Parameters used were C
A
D
CID
= 1
and the parameters from Figure 4.
Figure 8 shows the rate of product formation for various inhibitor concentrations [C]. Adding
more competitive inhibitor increases the probability of the inhibitor-bound states and thereby
drains probability out of those states competent to form product, as expected. Similarly to our
analysis of allosteric regulators, we can absorb the effects of the competitive inhibitor (CA,ID ) in
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Eq (50) into the enzyme parameters (εA,I , KA,IM ),
d[P]
dt
= [Etot ]
kAcate
−βεA(1+ [C]
CAD
) [S]
KAM
(
1+ [C]
CAD
) + kIcate−βεI(1+ [C]CID ) [S]KIM(1+ [C]CID )
e−βεA
(
1+ [C]
CAD
)(
1+ [S]
KAM
(
1+ [C]
CAD
))+ e−βεI(1+ [C]CID )(1+ [S]KIM(1+ [C]CID )
)
≡ [Etot ]
kAcate
−β ε˜A [S]
K˜AM
+ kIcate
−β ε˜I [S]
K˜IM
e−β ε˜A
(
1+ [S]
K˜AM
)
+ e−β ε˜I
(
1+ [S]K˜IM
) , (51)
where we have defined the new energies and Michaelis constants,
ε˜A = εA− 1β log
(
1+
[C]
CAD
)
(52)
ε˜I = εI− 1β log
(
1+
[C]
CID
)
(53)
K˜AM = K
A
M
(
1+
[C]
CAD
)
(54)
K˜IM = K
I
M
(
1+
[C]
CID
)
. (55)
Note that Eq (51) has exactly the same form as the rate of product formation of an MWC enzyme
without a competitive inhibitor, Eq (30). In other words, a competitive inhibitor modulates both the
effective energies and the Michaelis constants of the active and inactive states. Thus, an observed
value of KM may not represent a true Michaelis constant if an inhibitor is present. In the special
case of a Michaelis-Menten enzyme (e−βεI → 0), we recover the known result that a competitive
inhibitor only changes the apparent Michaelis constant.17
As shown for the allosteric regulator, the dynamic range and the concentration of substrate for
half-maximal rate of product formation [S50] follow from the analogous expressions for an MWC
enzyme (section 2.2, Eqs (33) and (35)) using the parameters ε˜A,I and K˜A,IM . Hence an allosteric
enzyme with one active site in the presence of a competitive inhibitor has a dynamic range given
by
dynamic range = [Etot ]kAcat
1− 1− k
I
cat
kAcat
1+ e−β (εA−εI)K
I
M
KAM
 (56)
and an [S50] value of
[S50] = KAM
e−β (εA−εI)
(
1+ [C]
CAD
)
+
(
1+ [C]CID
)
e−β (εA−εI)+ K
A
M
KIM
. (57)
Notice that Eq (56), the dynamic range of an MWC enzyme in the presence of a competitive
inhibitor, is exactly the same as Eq (33), the dynamic range in the absence of an inhibitor. This
makes sense because in the absence of substrate ([S]→ 0) the rate of product formation must be
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zero and at saturating substrate concentrations ([S]→ ∞) the substrate completely crowds out any
inhibitor concentration. Instead of altering the rate of product formation at these two limits, the
competitive inhibitor shifts the d[P]dt curve, and therefore [S50], to the right as more inhibitor is
added.
Said another way, adding a competitive inhibitor effectively rescales the concentration of sub-
strate in a system. Consider an MWC enzyme in the absence of a competitive inhibitor at a mea-
sured substrate concentration [Sno [C]]. Now consider a separate system where an enzyme is in the
presence of a competitive inhibitor at concentration [C] and at a measured substrate concentration
[Swith[C]]. It is straightforward to show that the rate of product formation
d[P]
dt is the same for both
enzymes,
d[P]
dt
= [Etot ]
kAcate
−βεA [Sno [C]]
KAM
+ kIcate
−βεI [Sno [C]]
KIM
e−βεA
(
1+
[Sno [C]]
KAM
)
+ e−βεI
(
1+
[Sno [C]]
KIM
)
= [Etot ]
kAcate
−βεA [Swith[C]]
KAM
+ kIcate
−βεI [Swith[C]]
KIM
e−βεA
(
1+
[Swith[C]]
KAM
+ [C]
CAD
)
+ e−βεI
(
1+
[Swith[C]]
KIM
+ [C]CID
) , (58)
provided that
[Swith[C]] =
e−β (εA−εI)
(
1+ [C]
CAD
)
+
(
1+ [C]CID
)
e−β (εA−εI)+1
[Sno [C]]. (59)
For any fixed competitive inhibitor concentration [C], this rescaling amounts to a constant multi-
plicative factor which results in a horizontal shift on a log scale of substrate concentration [S], as
is indeed shown in Figure 8.
As we have seen, the effects of both an allosteric regulator and a competitive inhibitor can
be absorbed into the parameters of an MWC enzyme. This suggests that experimental data from
enzymes that titrate these ligands can be collapsed into a 1-parameter family of curves where the
single parameter is either the concentration of an allosteric effector or a competitive inhibitor.
Indeed, in section 3.1 we shall find that this theory matches well with experimentally measured
activity curves.
2.5 Multiple Substrate Binding Sites
In 1965, Gerhart and Schachman used ultracentrifugation to determine that ATCase can be sepa-
rated into a large (100 kDa) catalytic subunit where substrate binds and a smaller (30 kDa) reg-
ulatory subunit which has binding sites for the allosteric regulators ATP and CTP.42 Their mea-
surements correctly predicted that ATCase had multiple active sites and multiple regulatory sites,
although their actual numbers were off (they predicted 2 active sites and 4 regulatory sites, whereas
ATCase has 6 active sites and 6 regulatory sites).13 Three years later, more refined sequencing by
Weber and crystallographic measurements by Wiley and Lipscomb revealed the correct quaternary
structure of ATCase.43–45
Many enzymes are composed of multiple subunits that contain substrate binding sites (also
called active sites or catalytic sites). Having multiple binding sites grants the substrate more loca-
18
tions to bind to an enzyme which increases the effective affinity between both molecules. A typical
enzyme will have between 1 and 6 substrate binding sites, and bindings sites for allosteric regula-
tors can appear with similar multiplicity. However, extreme cases exist such as hemocyanin which
can have as many as 48 active sites.46 Interestingly, across different species the same enzyme may
possess different numbers of active or regulatory sites, as well as be affected by other allosteric
regulators and competitive inhibitors.10,47 Furthermore, multiple binding sites may interact with
each other in a complex and often uncharacterized manner.48
We now extend the single-site model of an MWC enzyme introduced in Figure 3 to an MWC
enzyme with two substrate binding sites. Assuming that both binding sites are identical and inde-
pendent, the states and weights of the system are shown in Figure 9. When the enzyme is doubly
occupied EAS2, we assume that it forms product twice as fast as a singly occupied enzyme EAS.
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Figure 9: States and weights for an MWC enzyme with two substrate binding sites. Each binding
site acts independently and the rate of product formation of a doubly bound state is twice the rate of the
corresponding singly bound state.
It has been shown that in MWC models, explicit cooperative interaction energies are not re-
quired to accurately model biological systems; cooperativity is inherently built into the fact that all
binding sites switch concurrently from an active state to an inactive state.16 For example, suppose
an inactive state enzyme with two empty catalytic sites binds with its inactive state affinity KIM to
a single substrate, and that this binding switches the enzyme from the inactive to the active state.
Then the second, still empty, catalytic site now has the active state affinity KAM, an effect which can
be translated into cooperativity. Note that an explicit interaction energy, if desired, can be added to
the model very simply.
As in the proceeding sections, we compute the probability and concentration of each enzyme
conformation from the states and weights (see Eqs (23)-(29)). Because the active and inactive
conformations each have two singly bound states and one doubly bound state with twice the rate,
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the enzyme’s rate of product formation is given by
d[P]
dt
= kAcat (2pEAS)+2k
A
cat
(
pEAS2
)
+ kIcat (2pEIS)+2k
I
cat
(
pEIS2
)
= 2[Etot ]
kAcate
−βεA [S]
KAM
(
1+ [S]
KAM
)
+ kIcate
−βεI [S]
KIM
(
1+ [S]KIM
)
e−βεA
(
1+ [S]
KAM
)2
+ e−βεI
(
1+ [S]KIM
)2 (60)
We will have much more to say about this model in section 3.2.2, where we will show that d[P]dt as
a function of substrate concentration [S] may form a peak. For now, we mention the well-known
result that a Michaelis-Menten enzyme with two independent active sites will act identically to two
Michaelis-Menten enzymes each with a single active site (as can be seen in the εI → ∞ limit of
Eq (60)).17 It is intuitively clear that this result does not extend to MWC enzymes: d[P]dt for a two-
site MWC enzyme, Eq (60), does not equal twice the value of d[P]dt for a one-site MWC enzyme,
Eq (30).
2.6 Modeling Overview
The above sections allow us to model a complex enzyme with any number of substrate binding
sites, competitive inhibitors, and allosteric regulators. Assuming that the enzyme is in steady state
and that the cycle condition holds, we first enumerate its states and weights and then use those
weights to calculate the rate of product formation. Our essential conclusions about the roles of the
various participants in these reactions can be summarized as follows:
1. The (in)active state enzyme contributes a factor (e−βεI ) e−βεA to the weight. The mathemat-
ical simplicity of this model belies the complex interplay between the active and inactive
states. Indeed, an MWC enzyme cannot be decoupled into two Michaelis-Menten enzymes
(one for the active and the other for the inactive states).
2. Each bound substrate contributes a factor ( [S]KIM
) [S]
KAM
in the (in)active state where KM =
ko f f+kcat
kon
is a Michaelis constant between the substrate and enzyme. It is this Michaelis constant, and
not the dissociation constant, which enters the states and weights diagram.
3. Each bound allosteric regulator or competitive inhibitor X contributes a factor ( [X ]X Id
) [X ]
XAd
in the
(in)active state where XD =
kXo f f
kXon
is the dissociation constant between X and the enzyme. An
allosteric regulator R effectively tunes the energies of the active and inactive states as shown
in Eqs (45) and (46). A competitive inhibitor C effectively changes both the energies and
Michaelis constants of the active and inactive states as described by Eqs (52)-(55).
4. The simplest model for multiple binding sites assumes that each site is independent of the
others. The MWC model inherently accounts for the cooperativity between these sites, re-
sulting in sigmoidal activity curves despite no direct interaction terms.
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In Appendix B, we simultaneously combine all of these mechanisms by analyzing the rate of prod-
uct formation of ATCase (which has multiple binding sites) in the presence of substrate, a com-
petitive inhibitor, and allosteric regulators. In addition, the supplementary Mathematica notebook
lets the reader specify their own enzyme and see its corresponding properties.
Note that while introducing new components (such as a competitive inhibitor or an allosteric
regulator) introduces new parameters into the system, increasing the number of sites does not. For
example, an MWC enzyme with 1 (Figure 3), 2 (Figure 9), or more active sites would require the
same five parameters: e−β (εA−εI), KAM, KIM, kAcat , and kIcat .
3 Applications
Having built a framework to model allosteric enzymes, we now turn to some applications of how
this model can grant insights into observed enzyme behavior. Experimentally, the rate of product
formation of an enzyme is often measured relative to the enzyme concentration, a quantity called
activity,
A≡ 1
[Etot ]
d[P]
dt
. (61)
Enzymes are often characterized by their activity curves as substrate, inhibitor, and regulator con-
centrations are titrated. Such data not only determines important kinetic constants but can also
characterize the nature of molecular players such as whether an inhibitor is competitive, uncom-
petitive, mixed, or non-competitive.49–51 After investigating several activity curves, we turn to a
case study of the curious phenomenon of substrate inhibition, where saturating concentrations of
substrate inhibit enzyme activity, and propose a new minimal mechanism for substrate inhibition
caused solely by allostery.
3.1 Regulator and Inhibitor Activity Curves
We begin with an analysis of α-amylase, one of the simplest allosteric enzymes, which only has
a single catalytic site. α-amylase catalyzes the hydrolysis of large polysaccharides (e.g. starch
and glycogen) into smaller carbohydrates in human metabolism. It is competitively inhibited by
isoacarbose51 at the active site and is allosterically activated by Cl− ions at a distinct allosteric
site.52
Figure 10 plots substrate concentration divided by activity, [S]/A, as a function of substrate [S].
Recall from section 2.3 that an enzyme with one active site and one allosteric site has activity given
by Eq (43),
A =
kAcate
−βεA [S]
KAM
(
1+ [R]
RAD
)
+ kIcate
−βεI [S]
KIM
(
1+ [R]RID
)
e−βεA
(
1+ [S]
KAM
)(
1+ [R]
RAD
)
+ e−βεI
(
1+ [S]KIM
)(
1+ [R]RID
) . (62)
Thus we expect the [S]/A curves in Figure 10 to be linear in [S],
[S]
A
=
e−βεA
(
1+ [S]
KAM
)(
1+ [R]
RAD
)
+ e−βεI
(
1+ [S]KIM
)(
1+ [R]RID
)
kAcate−βεA 1KAM
(
1+ [R]
RAD
)
+ kIcate−βεI 1KIM
(
1+ [R]RID
) . (63)
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Figure 10: Theoretically and experimentally probing the effects of an allosteric regulator on activity.
Data points show experimentally measured activity from Feller et al. for the enzyme α-amylase using sub-
strate analog [S] (EPS) and allosteric activator [R] (NaCl).52 Best fit theoretical curves described by Eq (63)
are overlaid on the data. The best fit parameters are e−β (εA−εI) = 7.8×10−4, KAM = 0.6mM, KIM = 0.2mM,
RAD = 0.03mM, R
I
D = 7.9mM, k
A
cat = 14s
−1, and kIcat = 0.01s−1.
Figure 10 shows that the experimental data is well characterized by the theory so that the rate of
product formation at any other substrate and allosteric activator concentration can be predicted by
this model. The fitting procedure is discussed in detail in Appendix B.
In the special case of a Michaelis-Menten enzyme (εI → ∞), the above equation becomes
[S]
A
=
KAM +[S]
kAcat
(εI → ∞). (64)
The x-intercept of all lines in such a plot would intersect at the point (−KAM,0) which allows an
easy determination of KAM. This is why plots of [S] vs [S]/A, called Hanes plots, are often seen
in enzyme kinetics data. Care must be taken, however, when extending this analysis to allosteric
enzymes where the form of the x-intercept is more complicated.
We now turn to competitive inhibition. Figure 11(A) plots the inverse rate of product for-
mation
(
d[P]
dt
)−1
of α-amylase as a function of the competitive inhibitor concentration [C]. The
competitive inhibitor isoacarbose is titrated for three different concentrations of the substrate α-
maltotriosyl fluoride (αG3F).
Recall from section 2.4, Eq (50) that the rate of product formation for an allosteric enzyme
with one active site in the presence of a competitive inhibitor is given by
(
d[P]
dt
)−1
=
1
[Etot ]
e−βεA
(
1+ [S]
KAM
+ [C]
CAD
)
+ e−βεI
(
1+ [S]KIM
+ [C]CID
)
kAcate−βεA
[S]
KAM
+ kIcate−βεI
[S]
KIM
, (65)
so that the best fit
(
d[P]
dt
)−1
curves in Figure 11(A) are linear functions of [C]. Rather than thinking
of Eq (65) as a function of the competitive inhibitor concentration [C] and the substrate concen-
tration [S] separately, we can combine these two quantities into a single natural parameter for the
system. This will enable us to collapse the different activity curves in Figure 11(A) onto a single
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Figure 11: Theoretically and experimentally probing the effects of a competitive inhibitor on activity.
(A) Data points show experimentally measured activity in arbitrary units from Li et al. for the enzyme α-
amylase using substrate analog [S] (α-maltotriosyl fluoride) and competitive inhibitor [C] (isoacarbose).51
Best fit theoretical curves described by the inverse of Eq (65) are overlaid on the data. The best fit parameters
are e−β (εA−εI) = 36, KAM = 0.9mM, K
I
M = 2.6mM, C
A
D = 12nM, C
I
D = 260nM, and
kAcat
kIcat
= 1.4. Note that the
x-axis varies [C] rather than [S] as in most other plots. (B) A data collapse of the three curves using the
Bohr parameter ∆F from Eq (68) which encompasses the effects of both the substrate and inhibitor upon the
system.
master curve as shown in Figure 11(B). Algebraically manipulating Eq (65),
d[P]
dt
= [Etot ]
(
kAcate
−β (εA−εI)KIM
KAM
+ kIcat
)
[S]
KIM(
e−β (εA−εI)K
I
M
KAM
+1
)
[S]
KIM
+ e−β (εA−εI)
(
1+ [C]
CAD
)
+
(
1+ [C]CID
)
≡ [Etot ]
(
kAcatK+ k
I
cat
)
e−β∆F
(K+1)e−β∆F +1
(66)
where
K = e−β (εA−εI)
KIM
KAM
(67)
∆F =− 1
β
Log
 [S]KIM
e−β (εA−εI)
(
1+ [C]
CAD
)
+
(
1+ [C]CID
)
 . (68)
Therefore,
(
d[P]
dt
)−1
curves at any substrate and inhibitor concentrations can be compactly shown
as data points lying on a single curve in terms of ∆F , which is called the Bohr parameter. Such a
data collapse is also possible in the case of allosteric regulators or enzymes with multiples binding
sites, although those data collapses may require more than one variable ∆F . In Appendix C, we
show that the Bohr parameter corresponds to a free energy difference between enzyme states and
examine other cases of data collapse.
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3.2 Substrate Inhibition
We now turn to a striking phenomenon observed in the enzyme literature: not all enzymes have a
monotonically increasing rate of product formation. Instead peaks such as those shown schemat-
ically in Figure 12 can arise in various enzymes, displaying behavior that is impossible within
Michaelis-Menten kinetics. By exploring these two phenomena with the MWC model, we gain in-
sight into their underlying mechanisms and can make quantifiable predictions as to how to create,
amplify, or prevent such peaks.
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Figure 12: Enzyme activity curves do not need to be monotonic as predicted by Michaelis-Menten
enzyme kinetics. (A) As many as 20% of enzymes exhibit substrate inhibition, where at high substrate con-
centrations activity decreases, in contrast to a Michaelis-Menten enzyme shown for reference.53,54 Activity
for acetylcholinesterase is shown in units of (nanomoles product) ·min−1 · (mL enzyme)−1.55 (B) Some en-
zymes exhibit inhibitor acceleration, where adding a small amount of a competitive inhibitor increases the
rate of product formation. This generates a peak in activity, in stark contrast to a Michaelis-Menten enzyme
which only decreases its activity as more competitive inhibitor is added. Relative activity is shown for AT-
Case, where relative activity equals activity at [C] divided by the activity with no competitive inhibitor.10
The data and best fit parameters for the substrate inhibition and inhibitor acceleration curves are discussed
in Appendix C.
In Figure 12(A), the monotonically increasing Michaelis-Menten curve makes intuitive sense -
a larger substrate concentration implies that at any moment the enzyme’s active site is more likely
to be occupied by substrate. Therefore, we expect that the activity, A = 1[Etot ]
d[P]
dt , should increase
with the substrate concentration [S]. Yet many enzymes exhibit a peak activity, a behavior called
substrate inhibition.53
Even more surprisingly, when a small amount of competitive inhibitor - a molecule whose very
name implies that it competes with substrate and decreases activity - is mixed together with en-
zyme, it can increase the rate of product formation. This latter case, called inhibitor acceleration,
is shown in Figure 12(B).10,56 In contrast, a Michaelis-Menten enzyme shows the expected behav-
ior that adding more competitive inhibitor decreases activity. We will restrict our attention to the
phenomenon of substrate inhibition and relegate a discussion of inhibitor acceleration to Appendix
D.
Using the MWC enzyme model, we can make predictions about which enzymes can exhibit
substrate inhibition. We first formulate a relationship between the fundamental physical parameters
of an enzyme that are required to generate such a peak and then consider what information about
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these underlying parameters can be gained by analyzing experimental data.
3.2.1 Single-Site Enzyme
As a preliminary exercise, we begin by showing that an enzyme with a single active site cannot
exhibit substrate inhibition. Said another way, the activity, Eq (61), of such an enzyme cannot have
a peak as a function of substrate concentration [S]. For the remainder of this paper, we will use the
fact that all Michaelis and dissociation constants (KM’s, CD’s, and RD’s) are positive and assume
that both catalytic constants (kAcat and k
I
cat) are strictly positive unless otherwise stated.
Consider the MWC enzyme with a single substrate binding site shown in Figure 3. Using
Eq (30), it is straightforward to compute the derivative of activity with respect to substrate concen-
tration [S], namely,
dA
d[S]
=
(e−βεA + e−βεI)
(
e−βεA k
A
cat
KAM
+ e−βεI k
I
cat
KIM
)
(
e−βεA
(
1+ [S]
KAM
)
+ e−βεI
(
1+ [S]KIM
))2 . (69)
Since the numerator cannot equal zero, this enzyme cannot have a peak in its activity when [S] is
varied. Note that the numerator is positive, indicating that enzyme activity will always increase
with substrate concentration.
The above results are valid for an arbitrary MWC enzyme with a single-site. In particular, in
the limit εI→∞, an MWC enzyme becomes a Michaelis-Menten enzyme. Therefore, a Michaelis-
Menten enzyme with a single active site cannot exhibit a peak in activity. In Appendix E, we
discuss the generalization of this result: a Michaelis-Menten enzyme with an arbitrary number of
catalytic sites cannot have a peak in activity. Yet as we shall now see, this generalization cannot
be made for an MWC enzyme, which can indeed exhibit a peak in its activity when it has multiple
binding sites.
3.2.2 Substrate Inhibition
As many as 20% of enzymes are believed to exhibit substrate inhibition, which can offer unique
advantages to enzymes such as stabilizing their activity amid fluctuations, enhancing signal trans-
duction, and increasing cellular efficiency.54 This prevalent phenomenon has elicited various ex-
planations, many of which rely on non-equilibrium enzyme dynamics, although some equilibrium
mechanisms are known.53 An example of this latter case is seen in the enzyme aspartate transcar-
bamoylase (ATCase) which catalyzes one of the first steps in the pyrimidine biosynthetic pathway.
Before ATCase can bind to its substrate asparatate (Asp), an intermediate molecule carbamoyl
phosphate (CP) must first bind to ATCase, inducing a change in the enzyme’s shape and electro-
statics which opens up the Asp binding slot.57,58 Because Asp can weakly bind to the CP binding
pocket, at high concentrations Asp will outcompete CP and prevent the enzyme from working as
efficiently, thereby causing substrate inhibition.59
To the list of such mechanisms, we add the possibility that an enzyme may exhibit substrate
inhibition without any additional effector molecules. In particular, an allosteric enzyme with two
identical catalytic sites can exhibit a peak in activity when the substrate concentration [S] is varied.
We will first analyze the properties of this peak and then examine why it can occur. For simplicity,
we will assume kIcat = 0 throughout this section and leave the general case for Appendix E.
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Using Eqs (60) and (61), the activity of an MWC enzyme with two active sites is given by
A =
1
[Etot ]
d[P]
dt
=
2kAcate
−βεA [S]
KAM
(
1+ [S]
KAM
)
e−βεA
(
1+ [S]
KAM
)2
+ e−βεI
(
1+ [S]KIM
)2 . (70)
A peak will exist provided that dAd[S] = 0 has a positive [S] root. The details of differentiating and
solving this equation are given in Appendix E, the result of which is that a peak in activity A occurs
as a function of [S] provided that
1+ e−β (εA−εI) <
(
KAM
KIM
−1
)2
(kIcat = 0). (71)
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Figure 13: Peaks in enzyme activity A = 1Etot
d[P]
dt as a function of substrate concentration [S]. Activity
is shown in units of kAcat , which rescales the activity curves vertically. The peak for (A) small and (B) large
ratios of the enzyme’s energy in the active versus inactive state, e−β (εA−εI). The height of the peak increases
with e−β (εA−εI). The activity is computed from Eq (70) using the parameters kIcat = 0,
KAM
KIM
= 10, and the dif-
ferent values of e−β (εA−εI) shown. As predicted by Eq (71), every value in the range e−β (εA−εI) <
(
KAM
KIM
−1
)2
will yield a peak in activity. While the peak is more pronounced when the active state is energetically favor-
able (e−β (εA−εI) < 1) in (A), the maximum peak height is much larger in (B) as seen by the different scale of
the y-axis.
The height of such a peak is given by
Apeak = kAcat
KIM
KAM−KIM
(√
1+ e−β (εA−εI)−1
)
. (72)
Examples of peaks in activity are shown in Figure 13 for various values of e−β (εA−εI). Substituting
in the peak condition Eq (71), the maximum peak height is at most
Apeak < kAcat
KAM
KIM
−2
KAM
KIM
−1
. (73)
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If we consider the maximum value of e−β (εA−εI) allowed by the peak condition Eq (71), the
peak height approaches kAcat for large
KAM
KIM
(as seen by the green curve e−β (εA−εI) = 80 in Fig-
ure 13(B)). In this limit, the active bound state dominates over all the other enzyme states so that
the activity reaches its largest possible value, kAcat . Although the “peak height” is maximum in this
case, the activity curve is nearly sigmoidal, making the peak hard to distinguish. To that end, it is
reasonable to compare the peak height to the activity at large substrate concentrations,
A[S]→∞ = 2kAcat
e−β (εA−εI)(
KAM
KIM
)2
+ e−β (εA−εI)
. (74)
As the energy difference between the active and inactive state e−β (εA−εI) increases, the peak height
Apeak monotonically increases but the relative peak height
Apeak
A[S]→∞
monotonically decreases. These
relations might be used to design enzymes with particular activity curves; conversely, experimental
data of substrate inhibition can be used to fix a relation between the parameters e−β (εA−εI) and K
A
M
KIM
of an enzyme.
We now turn to the explanation of how such a peak can occur. One remarkable fact is that a
peak cannot happen without allostery. If we consider a Michaelis-Menten enzyme (by taking the
limit kIcat → 0 and εI → ∞), then the peak condition Eq (71) cannot be satisfied.
A[S ]→KMA
ac
tiv
ity
A[S ]→∞
[S ]KM
A [S ] ≈KM
A [S ] KM
A
= active state
= inactive state
Figure 14: Mechanism underlying peak in activation by substrate S. At low substrate concentrations
(left region), all enzymes are unbound and are mostly in the active form (rounded, green). As the amount of
substrate is increased (middle region), the probability that an enzyme is singly bound and then doubly bound
increase. Because the substrate prefers to bind to an inactive state (sharp, green) enzyme-substrate complex,
binding more substrate pushes the enzymes into the inactive state. At medium substrate concentrations, more
active state enzyme-substrate complexes exist than at high substrate concentrations (right region) which
yields a peak. Each enzyme fluctuates between its different configurations, and the cartoons show the
distributions of the most prevalent states.
To gain a qualitative understanding of how a peak can occur, consider an enzyme that inherently
prefers the active state (e−β (εA−εI) > 1) but with substrate that preferentially binds to the inactive
state (K
A
M
KIM
> 1). Such a system is realized in bacterial chemotaxis, where the chemotaxis receptors
are active when unbound but inactive when bound to substrate.32 This setup is shown schematically
in Figure 14. At low substrate concentrations, [S] KAM, most enzymes will be unbound and
27
therefore in the active state. At intermediate substrate concentrations, [S] ≈ KAM, many enzymes
will be singly bound. Because K
A
M
KIM
> 1, the substrate will pull these bound enzymes towards the
inactive state. For large substrate concentrations, [S] KAM, most of the enzymes will be doubly
bound and hence will be predominantly in the inactive form. Because the inactive state does not
catalyze substrate (kIcat = 0), only the number of substrate bound to active state enzymes increase
the rate of product formation, and because more of these exist in the intermediate regime a peak
forms.
To be more quantitative, the activity Eq (70) at the medium substrate concentration ([S] = KAM)
is given by
A[S]→KAM = k
A
cat
4e−β (εA−εI)(
KAM
KIM
+1
)2
+4e−β (εA−εI)
. (75)
Comparing this to A[S]→∞ in Eq (74), we find that A[S]→KAM > A[S]→∞ provided that
1+ e−β (εA−εI) <
1
4
(
KAM
KIM
−1
)2
. (76)
This is in close agreement with the peak condition Eq (71) and the factor of 14 is due to the fact that
the peak need not occur precisely at [S] = KAM.
Note that the peak condition Eq (71) does not necessarily force the unbound enzyme to favor the
active state (e−β (εA−εI) > 1), since this condition can still be satisfied if e−β (εA−εI) < 1. However,
the peak condition does require that substrate preferentially binds to the inactive state enzyme (in
fact, we must have K
A
M
KIM
> 2 to satisfy the peak condition).
Recall that as many as 20% of enzymes exhibit substrate inhibition, and this particular mech-
anism will not apply in every instance. To be concrete, an allosteric enzyme that obeys the mode
of substrate inhibition proposed above must: (1) have at least two catalytic sites and (2) must be
driven towards the inactive state upon substrate binding. Therefore, an enzyme such as ATCase
which exhibits substrate inhibition but where the substrate preferentially binds to the active state
enzyme must have a different underlying mechanism.60 Various alternative causes including the ef-
fects of pH due to substrate or product buildup17,61 or the sequestering effects of ions62,63 may also
be responsible for substrate inhibition. Yet the mechanism of substrate inhibition described above
exactly matches the conditions of acetylcholinesterase whose activity, shown in Figure 12(A), is
well categorized by the MWC model.55 It would be interesting to test this theory by taking a well
characterized enzyme, tuning the MWC parameters so as to satisfy the peak condition Eq (71) (or
an analogous relationship for an enzyme with more than two catalytic sites), and checking whether
the system then exhibits substrate inhibition. Experimentally, tuning the parameters can be under-
taken by introducing allosteric regulators or competitive inhibitors as described by Eqs (45)-(46)
and Eqs (52)-(55), respectively. For example, in Appendix E, we describe an enzyme system where
introducing a competitive inhibitor induces a peak in activity.
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4 Discussion
Allosteric molecules pervade all realms of biology from chemotaxis receptors to chromatin to
enzymes.15,64–66 There are various ways to capture the allosteric nature of macromolecules, with
the MWC model representing one among many.8,67,68 In any such model, the simple insight that
molecules exist in an active and inactive state opens a rich new realm of dynamics.
The plethora of molecular players that interact with enzymes serve as the building blocks to
generate complex behavior. In this paper, we showed the effects of competitive inhibitors, allosteric
regulators, and multiple binding sites, looking at each of these factors first individually and then
combining separate aspects. This framework matched well with experimental data and enabled
us to make quantifiable predictions on how the MWC enzyme parameters may be tuned upon the
introduction of an allosteric regulator Eqs (45)-(46) or a competitive inhibitor Eqs (52)-(55).
As an interesting application, we used the MWC model to explore the unusual behavior of
substrate inhibition, where past a certain point adding more substrate to a system decreases its rate
of product formation. This mechanism implies that an enzyme activity curve may have a peak (see
Figure 12), a feat that is impossible for a Michaelis-Menten enzyme. We explored a novel minimal
mechanism for substrate inhibition which rested upon the allosteric interactions of the active and
inactive enzyme states, with suggestive evidence for such a mechanism in acetylecholinesterase.
The power of the MWC model stems from its simple description, far-reaching applicability, and
its ability to unify the proliferation of data gained over the past 50 years of enzymology research.
A series of activity curves at different concentrations of a competitive inhibitor all fall into a 1-
parameter family of curves, allowing us to predict the activity at any other inhibitor concentration.
Such insights not only shed light on the startling beauty of biological systems but may also be
harnessed to build synthetic circuits and design new drugs. We close by noting our gratitude and
admiration to Prof. Bill Gelbart to whom this special is dedicated and who has inspired us with his
clever use of ideas from statistical physics to understand biological systems.
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